| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/26/2009 | EP1592408B1 Sustained release device and method for ocular delivery of adrenergic agents |
| 08/26/2009 | EP1567156B1 Hydroxypyridinones for the local treatment of skin microcirculatory disorders |
| 08/26/2009 | EP1553083B1 Prostaglandin derivatives |
| 08/26/2009 | EP1539700B1 8-hydroxy quinoline derivatives |
| 08/26/2009 | EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1524270B1 Sulfur-containing proanthocyanidin oligomer composition and process for producing the same |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1501804B1 Isoquinoline derivatives mao-b inhibitors |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1462442B1 Crystals of bicalutamide and process for their production |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1389089B1 Method and composition for solubilising a biologically active compound with low water solubility |
| 08/26/2009 | EP1328279B1 Compositions comprising lignin and methods of making and using the same |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1283675A4 Methods of modulating the activity of mura |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | EP1207879B1 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 08/26/2009 | EP1173441B1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations |
| 08/26/2009 | EP1173431B2 Method for the preparation of citalopram |
| 08/26/2009 | EP1082908B1 Additives for crustacean or fish feeds and feeds |
| 08/26/2009 | EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | CN201295317Y Contraceptive vaginal ring |
| 08/26/2009 | CN101517090A Mitotic progression genes and methods of modulating mitosis |
| 08/26/2009 | CN101517082A CpG oligonucleotide analogs containing hydrophobic T analogs with enhanced immunostimulatory activity |
| 08/26/2009 | CN101517081A RNAi-mediated inhibition of Gremlin for treatment of IOP-related conditions |
| 08/26/2009 | CN101517078A Methods of diagnosing and treating complications of pregnancy |
| 08/26/2009 | CN101516969A Targeted polylysine dendrimer therapeutic agent |
| 08/26/2009 | CN101516904A Dimeric IAP antagonists |
| 08/26/2009 | CN101516893A Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derevatives and their use in therapy |
| 08/26/2009 | CN101516891A Dihydrothieno pyrimidines as AKT protein kinase inhibitors |
| 08/26/2009 | CN101516890A Diaryl ketimine derivative |
| 08/26/2009 | CN101516888A Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use |
| 08/26/2009 | CN101516887A Thiazole pyrazolopyrimidines as CRF1 receptor antagonists |
| 08/26/2009 | CN101516886A Thiophene pyrazolopyrimidine compounds |
| 08/26/2009 | CN101516884A Octahydropyrrolo [3, 4-C] pyrrole derivatives an their use as antiviral agents |
| 08/26/2009 | CN101516883A Imidazopyrazines as protein kinase inhibitors |
| 08/26/2009 | CN101516882A Selective antagonists of A2A adenosine receptors |
| 08/26/2009 | CN101516881A 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 08/26/2009 | CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 08/26/2009 | CN101516878A Thiadiazole compound and use thereof |
| 08/26/2009 | CN101516877A 杂环有机化合物 Heterocyclic compounds |
| 08/26/2009 | CN101516876A Compounds having a potentiating effect on the activity of ethionamide and uses thereof |
| 08/26/2009 | CN101516875A CGRP receptor antagonists |
| 08/26/2009 | CN101516874A Pyrrole derivatives useful for the treatment of cytokine-mediated diseases |
| 08/26/2009 | CN101516873A Indazolyl derivatives useful as potassium channel modulating agents |
| 08/26/2009 | CN101516872A Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrile |
| 08/26/2009 | CN101516870A Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 08/26/2009 | CN101516869A Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 08/26/2009 | CN101516864A Process for the preparation of candesartan cilexetil form I |
| 08/26/2009 | CN101516860A Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors |
| 08/26/2009 | CN101516859A 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 08/26/2009 | CN101516858A Crystalline antifungal compounds |
| 08/26/2009 | CN101516853A Quinolinone derivatives |
| 08/26/2009 | CN101516852A Quinoline derivatives with 5-HT-binding properties |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/26/2009 | CN101516849A 5-phenyl-nicotinamide derivatives |
| 08/26/2009 | CN101516842A A crystalline form B4 of atorvastatin magnesium and a process thereof |
| 08/26/2009 | CN101516839A Compounds which modulate the cb2 receptor |
| 08/26/2009 | CN101516838A Soluble epoxide hydrolase inhibitors |
| 08/26/2009 | CN101516837A Sulfonamide derivatives |
| 08/26/2009 | CN101516833A Tartrate derivatives for use as coagulation factor IXa inhibitors |
| 08/26/2009 | CN101516826A Beta-3 receptor ligands and their use in therapy |
| 08/26/2009 | CN101516823A Phenyl-prenyl-ether derivatives for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 08/26/2009 | CN101516406A Method of optimizing the treatment of Philadelphia-positive leukemia with Abl tyrosine kinase inhibitors |
| 08/26/2009 | CN101516402A Gel type enteric nutrient |
| 08/26/2009 | CN101516392A Long-lasting absorption of flavonoids |
| 08/26/2009 | CN101516389A Combination therapy for treatment of viral infections |
| 08/26/2009 | CN101516386A Compositions comprising rosehip and other active agents for the treatment of inflammatory disorders |
| 08/26/2009 | CN101516384A Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 08/26/2009 | CN101516383A Methods and compositions for treating disease |
| 08/26/2009 | CN101516382A Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 08/26/2009 | CN101516381A Composition having effect of treating, preventing, or improving diabetes or diabetic complication and drink comprising the same |
| 08/26/2009 | CN101516380A Composition capable of reducing blood pressure and/or suppressing rise in blood temperature and drink containing same |
| 08/26/2009 | CN101516379A Kinase inhibitors useful for the treatment of proliferative diseases |
| 08/26/2009 | CN101516378A Morpholinyl and pyrrolidinyl analogs |
| 08/26/2009 | CN101516377A New medical use of triazine derivatives |
| 08/26/2009 | CN101516376A Method for treating cancer harboring EGFR mutations |
| 08/26/2009 | CN101516375A Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors |
| 08/26/2009 | CN101516374A Histone deacetylase inhibitors with combined activity on class-I and class-IIB histone deacetylases in combination with proteasome inhibitors |
| 08/26/2009 | CN101516373A Medicament for the enhancement of cognitive function and neuroprotection |
| 08/26/2009 | CN101516372A Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
| 08/26/2009 | CN101516371A Combination preparations comprising SLV308 and a L-dopa |
| 08/26/2009 | CN101516370A Alcohol free formulation of argatroban |
| 08/26/2009 | CN101516369A Pyridinone diketo acids: inhibitors of HIV replication in combination therapy |
| 08/26/2009 | CN101516368A Methods and medicaments for administration of ibuprofen |
| 08/26/2009 | CN101516367A Solid pharmaceutical composition for optically stable ramosetron |
| 08/26/2009 | CN101516366A Oxindole derivatives as anticancer agents |
| 08/26/2009 | CN101516365A Inhibitors of undecaprenyl pyrophosphate synthase |
| 08/26/2009 | CN101516364A Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 08/26/2009 | CN101516363A Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |
| 08/26/2009 | CN101516362A Polymeric conjugates containing positively-charged moieties |
| 08/26/2009 | CN101516361A Soluble epoxide hydrolase inhibitors |
| 08/26/2009 | CN101516360A Substituted acetylenic compounds useful for the treatment of diseases |
| 08/26/2009 | CN101516359A Medicament for lct poisoning |
| 08/26/2009 | CN101516358A Antiviral compositions and use thereof |
| 08/26/2009 | CN101516356A Metoprolol succinate e.r. tablets and methods for their preparation |
| 08/26/2009 | CN101516355A Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor Xa inhibitor |
| 08/26/2009 | CN101516352A Controlled release solid oral dosage formulations comprising nisoldipine |